awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38619164-92FC011A-900C-4251-A8CF-B85E12F55BED
Q38619164-92FC011A-900C-4251-A8CF-B85E12F55BED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38619164-92FC011A-900C-4251-A8CF-B85E12F55BED
SGLT2 inhibition: efficacy and safety in type 2 diabetes treatment.
P2860
Q38619164-92FC011A-900C-4251-A8CF-B85E12F55BED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38619164-92FC011A-900C-4251-A8CF-B85E12F55BED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
944b72fac50e82c9f03a4c4badc13ee71a11e992
P2860
Canagliflozin: a review of its use in patients with type 2 diabetes mellitus.